- Supported exchanges /
- ST /
- NXTCL.ST
NextCell Pharma AB (NXTCL ST) stock market data APIs
kr1.49
-0.24(-13.9%)
as of November 22, 2024
Price chart is built with Anychart
NextCell Pharma AB, a biopharmaceutical company, engages in the research, development, and manufacture of novel stromal cell therapies in Sweden. The company develops ProTrans, a drug candidate that consists of stem cells for the treatment of autoimmune disease, including type-1 diabetes. It also operates Cellaviva, a stem cell bank. The company was incorporated in 2014 and is based in Huddinge, Sweden.
NextCell Pharma AB Financial Data Overview
| 1.45 | |
| 1.49 | |
| - | |
| 1.49 | |
| 1.51 | |
| 1.0663-4.03 | |
| 129 M | |
| 73 091 K | |
| 11 278 K | |
| -0.2209 | |
| 0.714 |
Our easy-to-use no-coding solutions help you get the data effortlessly:
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
General: {
Code:
'NXTCL',
Type:
'Common Stock',
Name:
'NextCell Pharma AB',
Exchange:
'ST',
CurrencyCode:
'SEK',
CurrencyName:
'Swedish krone',
CurrencySymbol:
'kr',
CountryName:
'Sweden',
CountryISO:
'SE',
OpenFigi:
NULL,
ISIN:
'SE0009723125',
CIK:
NULL,
EmployerIdNumber:
NULL,
FiscalYearEnd:
'August',
IPODate:
NULL,
InternationalDomestic:
NULL,
Sector:
'Healthcare',
Industry:
'Biotechnology',
}
NextCell Pharma AB Fundamental Data is available in our Financial Data APIs
- Net Revenue 11 278 K
- EBITDA -42 197 452
- Earnings Per Share -0.57
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get NextCell Pharma AB Earnings via APIs
- Latest Release 2024-08-31
- EPS/Forecast NaN
Get NextCell Pharma AB End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Do you have any questions?
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
